SANTA ANA, Calif.—Johnson & Johnson Vision announced that the U.S. Food and Drug Administration (FDA) approval of the iDESIGN Refractive Studio, making it the only system to use topography-integrated, wavefront-guided technology. This allows doctors to take a precise measurement of the eye inside and out to deliver a LASIK procedure personalized to the individual patient, the company stated. It is now approved for myopia, hyperopia, and mixed astigmatism. Additionally, it is the only available LASIK platform indicated for monovision LASIK in presbyopic myopic patients.

"As a practicing ophthalmologist for more than 25 years, I know firsthand the importance of taking precise measurements and tailoring LASIK procedures for each patient," said Jonathan Talamo, MD, chief medical officer and worldwide vice president of medical and clinical affairs, Johnson & Johnson Vision. "The new iDESIGN Refractive Studio provides surgeons with the ability to deliver one-of-a-kind custom laser vision correction for each patient to have excellent visual outcomes following their LASIK procedure."

In a single, three-second scan, the iDESIGN Refractive Studio offers a new level of customization for patients. Each treatment plan begins with a wavefront analysis to measure how light travels inside the eye, detailing the imperfections in a patient's vision. The corneal topography scans the outside surface of the eye, measuring and analyzing tiny variations in curvature and elevation. The combination of the two measurements delivers a custom LASIK procedure tailored for each eye, J&J’s announcement said.

The iDESIGN Refractive Studio will be marketed by Johnson & Johnson Surgical Vision and be commercially available in Q3 2018, the company said.

Johnson & Johnson Vision’s iLASIK is an all-laser procedure that shapes the cornea to help improve a person's vision and the technology has been used in millions of procedures performed on Johnson & Johnson Vision machines around the world. Detailed information about LASIK is posted at BackinFocus.com.

In 2017, with the addition of Abbott Medical Optics Inc., the Johnson & Johnson Surgical Vision business, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK) and consumer eye health.